Page last updated: 2024-11-02

piracetam and Enterocolitis

piracetam has been researched along with Enterocolitis in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Enterocolitis: Inflammation of the MUCOSA of both the SMALL INTESTINE and the LARGE INTESTINE. Etiology includes ISCHEMIA, infections, allergic, and immune responses.

Research Excerpts

ExcerptRelevanceReference
"Levetiracetam (LEV) is a recently marketed novel anti-epileptic drug with a promising efficacy and safety profile."5.32Enterocolitis: an adverse event in refractory epilepsy patients treated with levetiracetam? ( Boon, P; Bosman, T; Claeys, P; De Clercq, M; De Reuck, J; Van Vlierberghe, H; Vonck, K, 2004)
"Levetiracetam (LEV) is a recently marketed novel anti-epileptic drug with a promising efficacy and safety profile."1.32Enterocolitis: an adverse event in refractory epilepsy patients treated with levetiracetam? ( Boon, P; Bosman, T; Claeys, P; De Clercq, M; De Reuck, J; Van Vlierberghe, H; Vonck, K, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosman, T1
Vonck, K1
Claeys, P1
Van Vlierberghe, H1
De Clercq, M1
De Reuck, J1
Boon, P1

Other Studies

1 other study available for piracetam and Enterocolitis

ArticleYear
Enterocolitis: an adverse event in refractory epilepsy patients treated with levetiracetam?
    Seizure, 2004, Volume: 13, Issue:2

    Topics: Adult; Anticonvulsants; Electroencephalography; Enterocolitis; Epilepsy; Female; Hippocampus; Humans

2004